FDA advisers endorse gene therapy to treat form of blindness


(Worthy News) – A potentially groundbreaking treatment for a rare form of blindness moved one step closer to U.S. approval Thursday, as federal health advisers endorsed the experimental gene therapy for patients with an inherited condition that gradually destroys eyesight.

The panel experts to the Food and Drug Administration voted unanimously in favor of Spark Therapeutics’ injectable therapy, which aims to improve vision by replacing a defective gene needed to process light.

The vote amounts to a recommendation to approve the therapy. The FDA has until mid-January to make its decision and does not have to follow the panel’s recommendation, though it often does.

If approved, Luxturna would be the first gene therapy in the U.S. for an inherited disease and the first in which a corrective gene is given directly to patients. While the therapy from Spark Therapeutics targets a small group of patients — about 2,000 in the U.S. — experts say it could pave the way for other genetic treatments for a variety of inherited conditions. [ Source (Read More…) ]

We're being CENSORED ... HELP get the WORD OUT! SHARE!!!

Latest Worthy News

100 Massacred In Nigeria’s Benue State, Amnesty Says (Worthy News In-Depth)
Israel Warns of Escalating Strikes as Warplanes Roam Tehran’s Skies
Trump and Putin Discuss Urgent Need to End Israel-Iran Conflict in Hour-Long Call
US Democratic Lawmaker, Husband Killed In ‘Politically Motivated Assassination’
Four Dead, 70 Injured As Iran-Israel Strikes Enter 2nd Day
Evangelist Graham: ‘Pray for Peace in Jerusalem’ As Fighting Escalates
San Antonio Mourns 11 Killed In Floods
Australians Attacked in Bali; Police Searching For Suspects
Air India Emergency Landing In Thailand After Bomb Threat
Fair Use Notice:This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond 'fair use', you must obtain permission from the copyright owner.

Worthy Christian News